A 52-year-old man with established rheumatoid arthritis (RF-positive, anti-CCP-positive) on methotrexate presents with new-onset dyspnea and bilateral interstitial infiltrates on chest X-ray. His rheumatologist suspects rheumatoid lung disease. Which investigation is most appropriate to confirm pulmonary involvement and assess disease severity?